ロード中...
Private Payer Coverage Policies for Whole Exome Sequencing (WES) in Pediatric Patients: Trends Over Time and Analysis of Evidence Cited
PURPOSE: Whole Exome Sequencing (WES) is being adopted for neurodevelopmental disorders in pediatric patients. However, little is known about current coverage policies or the evidence cited supporting these policies. Our study is the first in-depth review of private payer WES coverage policies for p...
保存先:
| 出版年: | Genet Med |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6329652/ https://ncbi.nlm.nih.gov/pubmed/29997388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41436-018-0043-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|